Literature DB >> 28940167

Th2-biased immune response and agglutinating antibodies generation by a chimeric protein comprising OmpC epitope (323-336) of Aeromonas hydrophila and LTB.

Mahima Sharma1, Pujarini Dash2, Pramod K Sahoo2, Aparna Dixit3.   

Abstract

Aeromonas hydrophila is responsible for causing fatal infections in freshwater fishes. Besides chemical/antibiotic treatment and whole-cell vaccine, no subunit vaccine is currently available for A. hydrophila. Outer membrane proteins of gram-negative bacteria have been reported as effective vaccine candidates. Peptide antigens elicit focused immune responses against immunodominant stretches of the antigen. We have attempted to characterize the immunogenicity of linear B-cell epitopes of outer membrane protein (OmpC) of A. hydrophila identified using in silico tools, in conjugation with heat-labile enterotoxin B (LTB) subunit of Escherichia coli as a carrier protein. Antisera against the fusion protein harboring 323-336 residues of the AhOmpC (raised in mice) showed maximum cross-reactivity with the parent protein OmpC and LTB. The fusion protein displayed efficient GM1 ganglioside receptor binding, retaining the adjuvanicity of LTB. Antibody isotype profile and in vitro T-cell response analysis, cytokine ELISA, and array analysis collectively revealed a Th2-biased mixed T-helper cell response. Agglutination assay and flow cytometry analysis validated the ability of anti-fusion protein antisera to recognize the surface exposed epitopes on Aeromonas cells, demonstrating its neutralization potential. Oral immunization studies in Labeo rohita resulted in the generation of long-lasting humoral immune response, and the antisera could cross-react with the fusion protein as well as both the fusion partners. Considering significant similarity among OmpC of different enteric bacteria, the use of A. hydrophila OmpC epitope323-336 in fusion with LTB could have a broader scope in vaccine design.

Entities:  

Keywords:  Aeromonas hydrophila; Agglutination; B cell; Epitope; LTB; OmpC

Mesh:

Substances:

Year:  2018        PMID: 28940167     DOI: 10.1007/s12026-017-8953-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  60 in total

1.  A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.

Authors:  Susanne Ebner; Susanne Hofer; Van Anh Nguyen; Christina Fürhapter; Manfred Herold; Peter Fritsch; Christine Heufler; Nikolaus Romani
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

Review 2.  IgG subclass distribution of antibodies to bacterial and viral antigens.

Authors:  A Ferrante; L J Beard; R G Feldman
Journal:  Pediatr Infect Dis J       Date:  1990-08       Impact factor: 2.129

Review 3.  More than one reason to rethink the use of peptides in vaccine design.

Authors:  Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

Review 4.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

5.  Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4(+) T cells.

Authors:  T O Nashar; Z E Betteridge; R N Mitchell
Journal:  Int Immunol       Date:  2001-04       Impact factor: 4.823

6.  Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.

Authors:  Manpreet Kaur; Hema Chug; Harpreet Singh; Subhash Chandra; Manish Mishra; Meenakshi Sharma; Rakesh Bhatnagar
Journal:  Mol Immunol       Date:  2009-04-07       Impact factor: 4.407

7.  Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci.

Authors:  S Pruksakorn; B Currie; E Brandt; C Phornphutkul; S Hunsakunachai; A Manmontri; J H Robinson; M A Kehoe; A Galbraith; M F Good
Journal:  Int Immunol       Date:  1994-08       Impact factor: 4.823

8.  Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.

Authors:  Anurag Sharma; Anja Krause; Yaqin Xu; Biin Sung; Wendy Wu; Stefan Worgall
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Prediction and identification of potential immunodominant epitopes in glycoproteins B, C, E, G, and I of herpes simplex virus type 2.

Authors:  Mingjie Pan; Xingsheng Wang; Jianmin Liao; Dengke Yin; Suqin Li; Ying Pan; Yao Wang; Guangyan Xie; Shumin Zhang; Yuexi Li
Journal:  Clin Dev Immunol       Date:  2012-05-09

10.  Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance.

Authors:  Jordi Vila; Joaquin Ruiz; Francisco Gallardo; Martha Vargas; Lara Soler; Maria José Figueras; Joaquin Gascon
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  2 in total

1.  Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan.

Authors:  Muhammad Hidayat Rasool; Asif Mehmood; Muhammad Saqalein; Muhammad Atif Nisar; Ahmad Almatroudi; Mohsin Khurshid
Journal:  Biomed Res Int       Date:  2021-01-29       Impact factor: 3.411

2.  Immunogenic and neutralization efficacy of recombinant perfringolysin O of Clostridium perfringens and its C-terminal receptor-binding domain in a murine model.

Authors:  Ankita Singh; Prashant Rawat; Devapriya Choudhury; Aparna Dixit
Journal:  Immunol Res       Date:  2022-01-15       Impact factor: 4.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.